JUN 04, 2020 6:30 AM PDT

Low T Cells Linked To High COVID Risk

WRITTEN BY: Tara Fernandez

German scientists have identified a connection between immune cell counts and the risk of developing severe, potentially life-threatening symptoms of COVID-19. The team, led by professor of virology, Ulf Dittmer, found that people who have low T cell counts at the time of infection have higher odds of developing a severe form of COVID-19. The study was published in the medical journal, The Lancet.

The numbers of a particular subpopulation of T cells, called cytotoxic T cells, in the blood were found to be central to this response. These immune cells protect the body by killing cancerous or virally-infected cells. 

It’s not just the number of T cells that count. The ratio of cytotoxic T cells to another type of immune cell, neutrophils, was also found to be important. T cells and neutrophils serve different but complementary roles in the protective immune response and have strong regulatory effects on each other.

“If there are too many neutrophils in the blood, they tend to suppress the function of T-cells. It can, therefore, be assumed that an elevated number of neutrophils in COVID-19 patients might contribute to a decrease in T cell counts,” explained Dittmer.

Common initial symptoms following coronavirus infection include fever, cough, fatigue, and diarrhea. More severe symptoms typically develop around a week later, in which the conditions of these patients rapidly deteriorate as acute respiratory distress syndrome, or ARDS, sets in. As symptoms progress, COVID-19 has also led to heart, kidney and liver damage and, in the worst cases, death. Being able to identify patients most at risk would allow physicians to initiate intensive interventions earlier and improve clinical outcomes.

 

 

The team’s investigation looked at 40 COVID-19 patients in Wuhan, China. Their studies suggest that a simple blood test for T cell and neutrophil counts should be done to quickly pick out at-risk COVID-19 patients. These patients need to be monitored more closely and perhaps be treated at an earlier stage, said Dittmer.

Patients receiving medications or therapies that can damage T cells, such as chemotherapy, should also be more closely monitored given this finding. 

The team’s finding also has implications for the development of a vaccine against the virus that causes COVID-19, SARS-CoV-2. A vaccine capable of shielding against infection may not only need to trigger the production of antibodies, but also activate T cell responses in order to confer robust protection.

 

Sources: Innovation Origins, The Lancet, The New England Journal of Medicine.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 16, 2020
Clinical & Molecular DX
Don't Sweat It! New Tech Monitors Health With a Single Drop of Sweat.
JUN 16, 2020
Don't Sweat It! New Tech Monitors Health With a Single Drop of Sweat.
Looking for ways to cool off and beat the summer heat? Think twice before wiping that sweat off your brow. Every drop of ...
JUN 25, 2020
Cardiology
Using RNA to Predict Acute Ischemic Strokes
JUN 25, 2020
Using RNA to Predict Acute Ischemic Strokes
Strokes are a leading cause of death and long term-disability across the globe. Ischemic strokes (IS) or acute ischemic ...
JUL 09, 2020
Clinical & Molecular DX
Women's Hair Holds Fertility Clues
JUL 09, 2020
Women's Hair Holds Fertility Clues
A new predictive tool for measuring women’s fertility uses an unlikely biological source for answers: hair. During ...
AUG 06, 2020
Clinical & Molecular DX
Device Diagnoses Breast Cancer in 60 Minutes
AUG 06, 2020
Device Diagnoses Breast Cancer in 60 Minutes
Researchers have created a point-of-care device that can provide diagnostic results for breast cancer in under an hour. ...
AUG 27, 2020
Clinical & Molecular DX
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
AUG 27, 2020
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
  Many diseases such as breast cancer have both a strong genetic component, coupled with a variety of environmental ...
SEP 16, 2020
Cancer
Does Discontinuation of Immunotherapy Effect Final Results in Metastatic Melanoma?
SEP 16, 2020
Does Discontinuation of Immunotherapy Effect Final Results in Metastatic Melanoma?
The last decade has seen the emergence of several new therapies against cancer. For melanoma, checkpoint inhibitors have ...
Loading Comments...